Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin: a Retrospective Study of Efficacy on Clinical and Isokinetic Criteria

NCT04004390 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04004390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04004390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin: a Retrospective Study of Efficacy on Clinical and Isokinetic Criteria
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
June 28, 2019
Completion date
December 30, 2019
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-poliomyélitis syndrom